Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Just noticed something interesting about the healthcare sector that might be worth paying attention to. The healthcare ETF space has been pretty dynamic over the years, and there's actually a solid case for diversification within the sector itself rather than just going with the broad exposure plays.
So here's what caught my attention - when you look at the major healthcare ETFs, they perform differently depending on their underlying strategy. The broad-based healthcare ETF approach gives you exposure to pharma, biotech, devices, and healthcare providers all in one basket. That's the classic move if you want sector exposure without picking individual stocks.
But the more interesting play is looking at the specialized healthcare ETFs. Medical device manufacturers have historically been a source of strength, especially when you consider policy tailwinds. These companies tend to move on different catalysts than pharma or biotech, so you get actual diversification benefits even within the healthcare space.
Then there's the equal-weight methodology for healthcare ETFs. This is where it gets tactical. Instead of weighting by market cap like traditional healthcare ETFs do, equal-weight healthcare funds allocate more evenly across holdings. The performance difference can be meaningful - we're talking about potentially outperforming cap-weighted peers significantly over multi-year periods. The trade-off is you get less concentration in mega-cap pharma names and more exposure to healthcare providers and device makers.
Biotech is another angle worth considering. If you want focused exposure to large-cap biotech without stock-picking, there are dedicated healthcare ETFs for that. The biggest names in biotech tend to drive returns, but the downside is limited exposure to smaller innovative names that could deliver outsized gains.
The key takeaway here is that healthcare ETF selection is more nuanced than just picking the largest fund. Depending on your thesis - whether you're bullish on devices, biotech innovation, or providers - you can be pretty tactical about which healthcare ETF fits your portfolio. Worth doing some homework on the expense ratios and holdings to see which aligns with your view.